Regimen 1973 cyclophosphamide. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy4

Bone Marrow Antilymphocyte Serum Spleen T-Lymphocytes

Organisms5

Mice, Inbred Strains Mice, Inbred BALB C Mice, Inbred C57BL Mice, Inbred C3H Transplantation Chimera

Diseases63

Breast Neoplasms Lymphoma, Non-Hodgkin Leukopenia Cystitis Neutropenia Recurrence Wegener Granulomatosis Lupus Nephritis Anemia, Aplastic Lymphoma, Large B-Cell, Diffuse Graft vs Host Disease Vomiting Thrombocytopenia Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Leukemia, Lymphocytic, Chronic, B-Cell Multiple Myeloma Nausea Hodgkin Disease Carcinoma, Small Cell Hematologic Diseases Neoplasm Metastasis Lymphoma, Follicular Lymphoma Microscopic Polyangiitis Lung Neoplasms Neoplasms Neoplasm Recurrence, Local Nephrotic Syndrome Vasculitis Polyarteritis Nodosa Hypersensitivity, Delayed Lymphatic Metastasis Alopecia Disease Progression Ovarian Neoplasms Lymphoma, B-Cell Amenorrhea Lung Diseases, Interstitial Neoplasms, Experimental Leukemia Sarcoma, Experimental Precursor Cell Lymphoblastic Leukemia-Lymphoma Leukemia L1210 Infection Hematologic Neoplasms Primary Ovarian Insufficiency Churg-Strauss Syndrome Rhabdomyosarcoma Hepatic Veno-Occlusive Disease Lupus Erythematosus, Systemic Lymphoma, Mantle-Cell Remission, Spontaneous Bone Marrow Diseases Myelodysplastic Syndromes Leukemia, Myeloid, Acute Sarcoma, Ewing Agranulocytosis Stomatitis Disease Models, Animal Acute Disease Glomerulonephritis, Membranous Gliosarcoma Sarcoma, Yoshida

Chemicals and Drugs84

Cyclophosphamide Vincristine Doxorubicin Phosphoramide Mustards Antineoplastic Agents, Alkylating Prednisone Immunosuppressive Agents Methotrexate Etoposide Epirubicin Busulfan Fluorouracil Thiotepa Prednisolone Antibodies, Monoclonal, Murine-Derived Vidarabine Granulocyte Colony-Stimulating Factor Cisplatin Methylprednisolone Melphalan Carmustine Antineoplastic Agents Ifosfamide Azathioprine Bleomycin Mesna Mitoxantrone Cytarabine Paclitaxel Chlorambucil Procarbazine Carboplatin Dexamethasone Acrolein Alkylating Agents Taxoids Antibodies, Monoclonal Vinblastine Myeloablative Agonists Antilymphocyte Serum Mechlorethamine Mycophenolic Acid Anthracyclines Amifostine Lomustine Antibiotics, Antineoplastic Cyclosporine Prodrugs Antibodies, Antineutrophil Cytoplasmic Ondansetron Vindesine Glucocorticoids Leucovorin Antiemetics Antineoplastic Agents, Phytogenic Antibodies, Monoclonal, Humanized Thalidomide Deoxycytidine Dacarbazine Misonidazole Cytochrome P-450 CYP2B1 Cladribine Recombinant Proteins Organothiophosphorus Compounds Drug Combinations Etanidazole Boronic Acids Pentostatin Mutagens Topotecan Pyrazines Teniposide Semustine Adrenal Cortex Hormones Granulocyte-Macrophage Colony-Stimulating Factor Prochlorperazine Oxidoreductases, N-Demethylating Altretamine Dactinomycin 6-Mercaptopurine Tamoxifen Antigens, CD34 Anti-HIV Agents Antimetabolites, Antineoplastic

Analytical, Diagnostic and Therapeutic Techniques and Equipment57

Antineoplastic Combined Chemotherapy Protocols Drug Administration Schedule Treatment Outcome Combined Modality Therapy Pulse Therapy, Drug Drug Therapy, Combination Remission Induction Disease-Free Survival Bone Marrow Transplantation Transplantation, Autologous Survival Analysis Hematopoietic Stem Cell Transplantation Whole-Body Irradiation Transplantation Conditioning Survival Rate Chemotherapy, Adjuvant Administration, Metronomic Follow-Up Studies Immunosuppression Transplantation, Homologous Infusions, Intravenous Administration, Oral Hematopoietic Stem Cell Mobilization Neoplasm Staging Prospective Studies Prognosis Leukocyte Count Salvage Therapy Retrospective Studies Clinical Trials as Topic Drug Evaluation Injections, Intravenous Neoadjuvant Therapy Random Allocation Actuarial Analysis Pilot Projects Leukapheresis Neoplasm Transplantation Feasibility Studies Bone Marrow Purging Treatment Failure Peripheral Blood Stem Cell Transplantation Plasmapheresis Mastectomy, Radical Immunization, Passive Immunotherapy Neoplasms, Experimental Blood Cell Count Sarcoma, Experimental Kaplan-Meier Estimate Maximum Tolerated Dose Area Under Curve Hemibody Irradiation Randomized Controlled Trials as Topic Premedication Disease Models, Animal Double-Blind Method

Phenomena and Processes15

Dose-Response Relationship, Drug Time Factors Leukocyte Count Graft Survival Biotransformation Drug Synergism Blood Cell Count Drug Resistance Antibody Formation Maximum Tolerated Dose Area Under Curve Remission, Spontaneous Premenopause Graft Rejection Drug Resistance, Neoplasm

Information Science1

Health Care17

Treatment Outcome Disease-Free Survival Survival Analysis Survival Rate Follow-Up Studies Prospective Studies Retrospective Studies Clinical Trials as Topic Random Allocation Actuarial Analysis Pilot Projects Feasibility Studies Treatment Failure Kaplan-Meier Estimate Area Under Curve Randomized Controlled Trials as Topic Double-Blind Method

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Information Science Health Care

Cyclophosphamide Antineoplastic Combined Chemotherapy Protocols Vincristine Doxorubicin Phosphoramide Mustards Antineoplastic Agents, Alkylating Prednisone Drug Administration Schedule Immunosuppressive Agents Treatment Outcome Methotrexate Etoposide Combined Modality Therapy Epirubicin Pulse Therapy, Drug Busulfan Drug Therapy, Combination Fluorouracil Remission Induction Thiotepa Prednisolone Breast Neoplasms Disease-Free Survival Antibodies, Monoclonal, Murine-Derived Vidarabine Lymphoma, Non-Hodgkin Bone Marrow Transplantation Leukopenia Dose-Response Relationship, Drug Granulocyte Colony-Stimulating Factor Transplantation, Autologous Survival Analysis Hematopoietic Stem Cell Transplantation Whole-Body Irradiation Transplantation Conditioning Survival Rate Chemotherapy, Adjuvant Cisplatin Methylprednisolone Time Factors Melphalan Cystitis Carmustine Administration, Metronomic Antineoplastic Agents Ifosfamide Neutropenia Recurrence Follow-Up Studies Immunosuppression Azathioprine Bleomycin Mesna Transplantation, Homologous Infusions, Intravenous Mitoxantrone Cytarabine Wegener Granulomatosis Lupus Nephritis Paclitaxel Chlorambucil Procarbazine Administration, Oral Carboplatin Hematopoietic Stem Cell Mobilization Dexamethasone Neoplasm Staging Prospective Studies Prognosis Acrolein Leukocyte Count Alkylating Agents Salvage Therapy Taxoids Anemia, Aplastic Lymphoma, Large B-Cell, Diffuse Retrospective Studies Graft vs Host Disease Vomiting Clinical Trials as Topic Antibodies, Monoclonal Drug Evaluation Vinblastine Thrombocytopenia Injections, Intravenous Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Leukemia, Lymphocytic, Chronic, B-Cell Multiple Myeloma Nausea Neoadjuvant Therapy Myeloablative Agonists Bone Marrow Antilymphocyte Serum Hodgkin Disease Carcinoma, Small Cell Spleen Mechlorethamine Hematologic Diseases Random Allocation Neoplasm Metastasis

No FAQ available that match "regimen 1973 cyclophosphamide"